LOGO.png
Rafarma’s Global Pharmaceutical Strategy At A Glance
May 18, 2021 08:53 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern...
Rafarma To Expand Proton Therapy Centers
May 07, 2021 09:35 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey)...
Rafarma and Haifa Technopark Enter Talks for Joint Venture
April 30, 2021 09:31 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan...
LOGO.png
Rafarma Embarks on Aggressive Global Partnerships Plan
March 04, 2021 10:55 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given...
LOGO.png
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
January 29, 2021 10:30 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development...
LOGO.png
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer
December 09, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the previously-announced Biocogency...
LOGO.png
Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia
December 01, 2020 10:53 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia (https://vaccineslab.com/). ...
LOGO.png
Letter To Shareholders from Chairman Ilya Shpurov
November 09, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus , Nov. 09, 2020 (GLOBE NEWSWIRE) -- November 9, 2020 (GLOBE NEWSWIRE) Rafarma Pharmaceuticals, Inc. OTC:(RAFA) shares the following letter to shareholders from Chairman Ilya Shpurov:...
LOGO.png
Rafarma Closes Biocogency Merger
October 19, 2020 09:15 ET | RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated...
LOGO.png
Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya Shpurov
October 06, 2020 10:13 ET | RAFARMA PHARMACEUTICALS INC
Ljubljana, Slovenia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce approval of Ilya Shpurov receiving the majority of Preferred B shares,...